New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
TherapeuticsMD, Inc.
TXMD
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

16M

Drug Manufacturers - Specialty & Generic

Next Earning date - 09 May 2025

16M

Drug Manufacturers - Specialty & Generic

Next Earning date - 09 May 2025

1.40USD

Shape0.02 ( 1.45%)
Market Closed (as of May 08, 20:00 EDT)
favorite-chart

Relative Strenght

88
favorite-chart

Volume Buzz

-87%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

43%

Quote Panel

Shape
Updated May 9, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

TXMD

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$9M

Shape1279%

2025-Revenue

$0.16

ShapeNaN%

2025-EPS

$7M

Shape-605%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-3.13
vs -5.50

Q4.22

arrow
arrow

N/A

-3.55
vs -4.50

Q1.23

arrow
arrow

N/A

-0.24
vs -4.72

Q2.23

arrow
arrow

N/A

-0.24
vs -2.15

Q3.23

arrow
arrow

N/A

-0.13
vs -3.13

Q4.23

arrow
arrow

N/A

-0.08
vs -3.55

Q1.24

arrow
arrow

N/A

-0.07
vs -0.24

Q2.24

arrow
arrow

N/A

-0.09
vs -0.24

Q3.24

arrow
arrow

N/A

-0.05
vs -0.13

Q4.24

arrow
arrow

N/A

-0.05
vs -0.08

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-18%

20.9M  vs 25.4M

Q4.22

arrow
arrow

-94%

1.2M  vs 18.7M

Q1.23

arrow
arrow

-98%

416K  vs 19.3M

Q2.23

arrow
arrow

-98%

437K  vs 28.6M

Q3.23

arrow
arrow

-100%

-53000.00  vs 20.9M

Q4.23

arrow
arrow

-56%

502K  vs 1.2M

Q1.24

arrow
arrow

-25%

313K  vs 416K

Q2.24

arrow
arrow

-46%

234K  vs 437K

Q3.24

arrow
arrow

+1132%

547K  vs -53000

Q4.24

arrow
arrow

+33%

667K  vs 502K

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-11%

-0.11
vs -0.95

Q2.23

arrow
arrow

-8%

-0.08
vs -0.11

Q3.23

arrow
arrow

-12%

-0.12
vs -0.08

Q4.23

arrow
arrow

-3%

-0.03
vs -0.12

Q1.24

arrow
arrow

-3%

-0.03
vs -0.03

Q2.24

arrow
arrow

-4%

-0.04
vs -0.03

Q3.24

arrow
arrow

-2%

-0.02
vs -0.04

Q4.24

arrow
arrow

+1%

0.01
vs -0.02

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

41

41
vs 50

-18%

Q2.23

arrow
arrow

43

43
vs 41

5%

Q3.23

arrow
arrow

37

37
vs 43

-14%

Q4.23

arrow
arrow

37

37
vs 37

NA

Q1.24

arrow
arrow

43

43
vs 37

16%

Q2.24

arrow
arrow

37

37
vs 43

-14%

Q3.24

arrow
arrow

35

35
vs 37

-5%

Q4.24

arrow
arrow

39

39
vs 35

11%

Earnings Growth

Latest News